Neuroprotective Effect of PACAP Against NMDA-Induced Retinal Damage in the Mouse
- 12 August 2010
- journal article
- research article
- Published by Springer Nature in Journal of Molecular Neuroscience
- Vol. 43 (1) , 22-29
Abstract
Retinal excitotoxicity is one of the major causes of retinal ganglion cell (RGC) death in glaucoma. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a pleiotropic peptide with potent neuroprotective activity; however, whether it exerts such an effect in the retina and the mechanism by which RGCs are protected is still not well understood. In this study, we examined the effect of exogenous and endogenous PACAP on RGC death induced by N-methyl-d-aspartate acid (NMDA). The vitreous body of anesthetized adult male mice (C57/BL6J) was injected with NMDA (40 nmol in a 2 μL saline solution). The number of RGCs decreased from days 1 to 7 after NMDA injection, and the number of dUTP end-labeling (TUNEL)-positive cells, an indicator of cell death, peaked at day 3. However, when PACAP38 (10−8, 10−10, 10−12, 10−14, or 10−16M) was co-administered with NMDA, the 10−10M dose resulted in significantly increased RGC survival at day 7, and a decrease in the number of TUNEL-positive RGCs at day 3. We next investigated the neuroprotective effect of endogenous PACAP using PACAP heterozygote(+/−) mice. Under normal circumstances, there was no significant difference in the number of RGCs in the PACAP(+/−) mice compared with their wild-type counterparts. However, the number of RGCs significantly decreased in the PACAP(+/−) mice 7 days after NMDA injection, relative to their wild-type counterparts. The number of TUNEL-positive RGCs peaked at day 1 in the PACAP(+/−) mice. These effects in the PACAP(+/−) mice were reversed by intravitreous injection of 10−10M PACAP38. This suggests that exogenous PACAP is able to counteract NMDA-induced toxicity, and that endogenous PACAP exerts a neuroprotective effect in the retina.Keywords
This publication has 37 references indexed in Scilit:
- Experimental Glutamatergic Excitotoxicity in Rabbit Retinal Ganglion Cells: Block by MemantineInvestigative Ophthalmology & Visual Science, 2009
- Effects of Pituitary Adenylate Cyclase Activating Polypeptide and Its Fragments on Retinal Degeneration Induced by Neonatal Monosodium Glutamate TreatmentAnnals of the New York Academy of Sciences, 2009
- Signaling involved in pituitary adenylate cyclase-activating polypeptide-stimulated ADNP expressionPeptides, 2006
- Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6Proceedings of the National Academy of Sciences, 2006
- Endogenous PACAP acts as a stress response peptide to protect cerebellar neurons from ethanol or oxidative insultPeptides, 2005
- Pituitary Adenylate Cyclase-activating Polypeptide (PACAP(1–38)) Enhances N-Methyl-d-aspartate Receptor Function and Brain-derived Neurotrophic Factor Expression via RACK1Journal of Biological Chemistry, 2003
- The Origin and Function of the Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP)/Glucagon SuperfamilyEndocrine Reviews, 2000
- Distribution and Ultrastractural Localization of Pituitary Adenylate Cyclase‐Activating Polypeptide (PACAP) and Its Receptor in the Rat RetinaaAnnals of the New York Academy of Sciences, 1998
- Ganglion cell death in glaucoma: pathology recapitulates ontogenyAustralian and New Zealand Journal of Ophthalmology, 1995
- Pituitary Adenylate Cyclase Activating Polypeptide (PACAP) and Its Receptors: Neuroendocrine and Endocrine InteractionFrontiers in Neuroendocrinology, 1995